Evidence map›Paper›PMID 37438910›Full record

ArticleVeterinary medicine and science2023

Serological survey of Leishmania infantum in apparently healthy dogs in different areas of Spain.

Marta Baxarias, Cristina Mateu, Guadalupe Miró, Laia Solano-Gallego

Abstract read
In one paragraph

Article in Veterinary medicine and science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Molecular Prevalence ofPathogens (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Genetic Variability in Leishmaniasis-CausingAnimals : an open access journal from MDPI · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Fatal disseminatedJFMS open reports
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marta BaxariasDepartament de Medicina I Cirurgia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona, Bellaterra, Spain.ORCID 0000-0002-1830-4366
Cristina MateuEcuphar Veterinaria SLU, Sant Cugat del Vallès, Barcelona, Spain.
Guadalupe MiróAnimal Health Department, Veterinary Faculty, Universidad Complutense de Madrid, Madrid, Spain.ORCID 0000-0003-0981-2470
Laia Solano-GallegoDepartament de Medicina I Cirurgia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona, Bellaterra, Spain.ORCID 0000-0001-8479-4896

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCanine leishmaniosis caused by Leishmania infantum is an endemic disease in Spain. The dog is considered the main reservoir, and the detection of specific serum antibodies against L. infantum antigen is the most used technique for diagnosing this infection. The LEISCAN LEISHMANIA ELISA test is a commercialized enzyme-linked immunosorbent assay for the detection and measurement of canine anti-Leishmania serum antibodies.

objectivesThe aim of this study was to assess seroprevalence results of apparently healthy dogs in different areas of Spain using LEISCAN.

methodsCollection of sera from 5451 apparently healthy dogs was performed between 2020 and 2021 in different areas of Spain. Dogs were of adult age (≥12 months), were not previously diagnosed with clinical leishmaniosis or vaccinated against Leishmania and did not present clinical signs compatible with L. infantum infection. LEISCAN was performed following the manufacturer's protocol.

resultsThe overall seroprevalence was 5.5%. The highest seroprevalences were found in the Southeast of Spain: Comunidad Valenciana (14%) and Región de Murcia (14%), whereas the lowest seroprevalences were found in Northern Spain: Galicia (1%), Navarra (2%) and Castilla y León (2%) (p-value <0.001).

conclusionsIn conclusion, the seroprevalence for L. infantum in apparently healthy dogs in Spain varied from almost no infection to being over 10%.

Indexed as

Leishmania infantumLeishmaniasisAnimalsAntibodies, ProtozoanDogsSeroepidemiologic StudiesSpainAntibodies, ProtozoancaninediagnosisELISAleishmaniosisseroprevalence

Identifiers

PMID37438910
PMCPMC10508519

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.